ROYAL BANK OF CANADA - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$4,000
-20.0%
32,689
+5.1%
0.00%
Q3 2022$5,00031,103
+31003.0%
0.00%
Q2 2022$0
-100.0%
100
-99.4%
0.00%
Q1 2022$8,000
+100.0%
16,287
+138.3%
0.00%
Q4 2021$4,000
-69.2%
6,836
-45.8%
0.00%
Q3 2021$13,000
-81.7%
12,608
-67.8%
0.00%
Q2 2021$71,000
-56.7%
39,102
-53.3%
0.00%
Q1 2021$164,000
+182.8%
83,657
+80.2%
0.00%
Q4 2020$58,000
-73.9%
46,414
-62.2%
0.00%
Q3 2020$222,000
-80.9%
122,945
-11.3%
0.00%
Q2 2020$1,161,000
+22.6%
138,542
-23.4%
0.00%
Q1 2020$947,000
+11.3%
180,753
+15.9%
0.00%
Q4 2019$851,000
+1.4%
155,897
-9.5%
0.00%
Q3 2019$839,000
-23.7%
172,336
+8.5%
0.00%
Q2 2019$1,100,000
-1.8%
158,820
-1.5%
0.00%
Q1 2019$1,120,000
+47.8%
161,250
+24.3%
0.00%
Q4 2018$758,000
-25.5%
129,745
-3.8%
0.00%
Q3 2018$1,018,000
+65.5%
134,804
+10.7%
0.00%
Q2 2018$615,000
+94.0%
121,772
+134.4%
0.00%
Q1 2018$317,000
+2338.5%
51,961
+2742.5%
0.00%
Q4 2017$13,000
-64.9%
1,828
-64.0%
0.00%
Q3 2017$37,000
+362.5%
5,076
+313.4%
0.00%
Q2 2017$8,000
-20.0%
1,228
+2.3%
0.00%
Q1 2017$10,0000.0%1,2000.0%0.00%
Q4 2016$10,000
+42.9%
1,200
+20.0%
0.00%
Q3 2016$7,000
+250.0%
1,000
+100.0%
0.00%
Q2 2015$2,0005000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders